Literature DB >> 26379091

Human Alpha-Defensin HNP1 Increases HIV Traversal of the Epithelial Barrier: A Potential Role in STI-Mediated Enhancement of HIV Transmission.

Kimyata Valere1, Aprille Rapista2, Eliseo Eugenin1,2, Wuyuan Lu3, Theresa L Chang1,2.   

Abstract

Alpha-defensins, including human neutrophil peptides 1-3 (HNP1-3) and human defensin 5 (HD5), are elevated at the genital mucosa in individuals with sexually transmitted infections (STIs). The presence of STIs is associated with an increased risk of human immunodeficiency virus (HIV) transmission, suggesting there may be a role for defensins in early events of HIV transmission. HD5 has been demonstrated to contribute to STI-mediated increased HIV infectivity in vitro. HNPs exhibit anti-HIV activity in vitro. However, increased levels of HNPs have been associated with enhanced HIV acquisition and higher viral load in breast milk. This study found that HNP1, but not HD5, significantly disrupted epithelial integrity and promoted HIV traversal of epithelial barriers. Linear HNP1 with the same charges did not affect epithelial permeability, indicating that the observed effect of HNP1 on the epithelial barrier was structure dependent. These results suggest a role for HNP1 in STI-mediated enhancement of HIV transmission.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26379091      PMCID: PMC4677513          DOI: 10.1089/vim.2014.0137

Source DB:  PubMed          Journal:  Viral Immunol        ISSN: 0882-8245            Impact factor:   2.257


  36 in total

Review 1.  The role of sexually transmitted diseases in HIV transmission.

Authors:  Shannon R Galvin; Myron S Cohen
Journal:  Nat Rev Microbiol       Date:  2004-01       Impact factor: 60.633

2.  Dual role of alpha-defensin-1 in anti-HIV-1 innate immunity.

Authors:  Theresa L Chang; Jesus Vargas; Armando DelPortillo; Mary E Klotman
Journal:  J Clin Invest       Date:  2005-03       Impact factor: 14.808

3.  Vaginal transmission of SIV: assessing infectivity and hormonal influences in macaques inoculated with cell-free and cell-associated viral stocks.

Authors:  D L Sodora; A Gettie; C J Miller; P A Marx
Journal:  AIDS Res Hum Retroviruses       Date:  1998-04       Impact factor: 2.205

4.  Transcytosis of infectious human immunodeficiency virus across a tight human epithelial cell line barrier.

Authors:  M Bomsel
Journal:  Nat Med       Date:  1997-01       Impact factor: 53.440

5.  Synthesis and characterization of human alpha-defensins 4-6.

Authors:  Z Wu; B Ericksen; K Tucker; J Lubkowski; W Lu
Journal:  J Pept Res       Date:  2004-09

6.  The junction-associated protein, zonula occludens-1, localizes to the nucleus before the maturation and during the remodeling of cell-cell contacts.

Authors:  C J Gottardi; M Arpin; A S Fanning; D Louvard
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-01       Impact factor: 11.205

7.  Human epithelial beta-defensins 2 and 3 inhibit HIV-1 replication.

Authors:  Miguel E Quiñones-Mateu; Michael M Lederman; Zhimin Feng; Bikram Chakraborty; Jan Weber; Hector R Rangel; Michael L Marotta; Muneer Mirza; Bin Jiang; Patti Kiser; Kathy Medvik; Scott F Sieg; Aaron Weinberg
Journal:  AIDS       Date:  2003-11-07       Impact factor: 4.177

8.  Toll-like receptor 2 enhances ZO-1-associated intestinal epithelial barrier integrity via protein kinase C.

Authors:  Elke Cario; Guido Gerken; Daniel K Podolsky
Journal:  Gastroenterology       Date:  2004-07       Impact factor: 22.682

9.  Defensins reduce the barrier integrity of a cultured epithelial monolayer without cytotoxicity.

Authors:  S D Nygaard; T Ganz; M W Peterson
Journal:  Am J Respir Cell Mol Biol       Date:  1993-02       Impact factor: 6.914

10.  Activity of alpha- and theta-defensins against primary isolates of HIV-1.

Authors:  Wei Wang; Sherry M Owen; Donna L Rudolph; Alexander M Cole; Teresa Hong; Alan J Waring; Renu B Lal; Robert I Lehrer
Journal:  J Immunol       Date:  2004-07-01       Impact factor: 5.422

View more
  9 in total

Review 1.  Defensins at the Mucosal Surface: Latest Insights into Defensin-Virus Interactions.

Authors:  Sarah S Wilson; Mayim E Wiens; Mayumi K Holly; Jason G Smith
Journal:  J Virol       Date:  2016-05-12       Impact factor: 5.103

Review 2.  Cathelicidins and defensins antimicrobial host defense peptides in the treatment of TB and HIV: Pharmacogenomic and nanomedicine approaches towards improved therapeutic outcomes.

Authors:  Prince N Dlozi; Angelina Gladchuk; Rustin D Crutchley; Nicole Keuler; Renier Coetzee; Admire Dube
Journal:  Biomed Pharmacother       Date:  2022-05-28       Impact factor: 7.419

Review 3.  The Role of Antimicrobial Peptides in Influenza Virus Infection and Their Potential as Antiviral and Immunomodulatory Therapy.

Authors:  I-Ni Hsieh; Kevan L Hartshorn
Journal:  Pharmaceuticals (Basel)       Date:  2016-09-06

Review 4.  The Role of Defensins in HIV Pathogenesis.

Authors:  Barcley T Pace; Andrew A Lackner; Edith Porter; Bapi Pahar
Journal:  Mediators Inflamm       Date:  2017-08-03       Impact factor: 4.711

Review 5.  Defensins: A Double-Edged Sword in Host Immunity.

Authors:  Dan Xu; Wuyuan Lu
Journal:  Front Immunol       Date:  2020-05-07       Impact factor: 7.561

Review 6.  Impedance Spectroscopy as a Tool for Monitoring Performance in 3D Models of Epithelial Tissues.

Authors:  Tatiana Gerasimenko; Sergey Nikulin; Galina Zakharova; Andrey Poloznikov; Vladimir Petrov; Ancha Baranova; Alexander Tonevitsky
Journal:  Front Bioeng Biotechnol       Date:  2020-01-24

Review 7.  Interactions of HIV and Antiretroviral Therapy With Neutrophils and Platelets.

Authors:  Morris Madzime; Theresa M Rossouw; Annette J Theron; Ronald Anderson; Helen C Steel
Journal:  Front Immunol       Date:  2021-03-12       Impact factor: 7.561

Review 8.  The Interplay Between Cervicovaginal Microbial Dysbiosis and Cervicovaginal Immunity.

Authors:  Ya Wang; Xiaoli Wang; Meiling Zhu; Li Ge; Xiaochen Liu; Kaikai Su; Zhengzheng Chen; Weidong Zhao
Journal:  Front Immunol       Date:  2022-03-10       Impact factor: 7.561

Review 9.  Antiviral Activities of Human Host Defense Peptides.

Authors:  David C Brice; Gill Diamond
Journal:  Curr Med Chem       Date:  2020       Impact factor: 4.530

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.